News & Updates

Sibylla Biotech Enters a Strategic Drug Discovery Collaboration with Ono Pharmaceutical in Central Nervous System...

Sibylla Biotech Raises €23 Million Series A to Advance Protein Degradation by Folding Interference Pipeline and Expand...

Giovanni Spagnolli appointed as CTO of Sibylla Biotech

Sibylla Biotech selected by Nature among the eight best start-ups in the world in the life-science sector Sibylla...

Sibylla Biotech will use its Drug Discovery platform to modulate the activity of targets supplied by Takeda. The...

The scientific paper about PPI-FIT technology and its first validation is now published on Nature Communications...

New structural target against COVID-19 A new structural target for drug development against COVID-19 has been unveiled...

A documentary on Sibylla Biotech broadcasted on TV 4.0 La fabbrica del futuro

Interview with one of the inventor of the PPI-FIT technology and co-founder of Sibylla Biotech 

Watch the interview in italian

Watch the press release in italian Interview link

Lidia Pieri appointed as CEO of Sibylla Biotech